The Journal of Immunology, Vol 154, Issue 6 2642-2654, Copyright © 1995 by American Association of Immunologists

ARTICLES

Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition

MD Mannie, JM Rosser and GA White
Department of Microbiology and Immunology, East Carolina University School of Medicine, Greenville, NC 27858.

A central question of TCR function is based on the observation that some MHC ligands may bind TCR without stimulating biologic activity. To address the role of CD4 in this mechanism, we studied the interactions of the anti-CD4 mAb W3/25 with an encephalitogenic line of T helper cells. Proliferative responses to guinea pig (GP) myelin basic protein (GPMBP) were mediated by distinct W3/25-sensitive and W3/25-insensitive mechanisms whereas responses to autologous rat (R) MBP (RMBP) were exclusively mediated by W3/25-sensitive pathways. In assays of IL-2 production, RMBP was a partial agonist that stimulated an intermediate level of IL-2 production but antagonized high levels of GPMBP- stimulated IL-2 production to that intermediate level. In the presence of W3/25, RMBP lacked stimulatory activity but instead exhibited inhibitory activity that completely blocked GPMBP-stimulated proliferative responses. The inhibitory mechanism did not involve antigenic competition for MHC glycoproteins, a blockade of mitogenic signaling, or induction of high zone tolerance. Rather, the mechanism involved specific occupancy of TCR with antagonistic MHC ligands derived from the 72-86 region of RMBP. In proliferative assays, GPMBP was approximately 10-fold more active than RMBP. In the presence of W3/25 however, GPMBP-induced agonism and RMBP-induced antagonism exhibited overlapping dose-response curves. RMBP and W3/25 not only fully inhibited GPMBP-stimulated proliferation, this synergistic combination also elicited an extended phase of T cell energy. In conclusion, RMBP-derived MHC ligands occupy TCR to exhibit full efficacy for CD4-dependent signaling pathways while simultaneously lacking efficacy for W3/25-resistant signaling pathways. These data support an "integrative" model of T cell Ag recognition whereby MHC glycoproteins actively guide specific clustering of MHC-ligated TCR to enable quantitative comparisons of efficacious (nonself) and nonefficacious (self) signals by T cells.

This article has been cited by other articles:

				Q. Wang, L. Malherbe, D. Zhang, K. Zingler, N. Glaichenhaus, and N. Killeen CD4 Promotes Breadth in the TCR Repertoire J. Immunol., October 15, 2001; 167(8): 4311 - 4320. [Abstract] [Full Text] [PDF]

				T. L. Geiger, P. Nguyen, D. Leitenberg, and R. A. Flavell Integrated src kinase and costimulatory activity enhances signal transduction through single-chain chimeric receptors in T lymphocytes Blood, October 15, 2001; 98(8): 2364 - 2371. [Abstract] [Full Text] [PDF]

				G. Denkberg, C. J. Cohen, and Y. Reiter Critical Role for CD8 in Binding of MHC Tetramers to TCR: CD8 Antibodies Block Specific Binding of Human Tumor- Specific MHC-Peptide Tetramers to TCR J. Immunol., July 1, 2001; 167(1): 270 - 276. [Abstract] [Full Text] [PDF]

				K. Vidal, C. Daniel, M. Hill, D. R. Littman, and P. M. Allen Differential Requirements for CD4 in TCR-Ligand Interactions J. Immunol., November 1, 1999; 163(9): 4811 - 4818. [Abstract] [Full Text] [PDF]

				R. Wang, Y. Wang-Zhu, C. R. Gabaglia, K. Kimachi, and H. M. Grey The Stimulation of Low-Affinity, Nontolerized Clones by Heteroclitic Antigen Analogues Causes the Breaking of Tolerance Established to an Immunodominant T Cell Epitope J. Exp. Med., October 4, 1999; 190(7): 983 - 994. [Abstract] [Full Text] [PDF]

				J. Thatte, A. Qadri, C. Radu, and E. S. Ward Molecular Requirements for T Cell Recognition by a Major Histocompatibility Complex Class II-restricted T Cell Receptor: The Involvement of the Fourth Hypervariable Loop of the Valpha Domain J. Exp. Med., February 1, 1999; 189(3): 509 - 520. [Abstract] [Full Text] [PDF]

				P. R. Rogers, H. M. Grey, and M. Croft Modulation of Naive CD4 T Cell Activation with Altered Peptide Ligands: The Nature of the Peptide and Presentation in the Context of Costimulation Are Critical for a Sustained Response J. Immunol., April 15, 1998; 160(8): 3698 - 3704. [Abstract] [Full Text] [PDF]

				A. Viola, M. Salio, L. Tuosto, S. Linkert, O. Acuto, and A. Lanzavecchia Quantitative Contribution of CD4 and CD8 to T Cell Antigen Receptor Serial Triggering J. Exp. Med., November 17, 1997; 186(10): 1775 - 1779. [Abstract] [Full Text] [PDF]

				J. A. Smith, J. Y. Tso, M. R. Clark, M. S. Cole, and J. A. Bluestone Nonmitogenic Anti-CD3 Monoclonal Antibodies Deliver a Partial T Cell Receptor Signal and Induce Clonal Anergy J. Exp. Med., April 21, 1997; 185(8): 1413 - 1422. [Abstract] [Full Text] [PDF]

				B. M. Kessler, P. Bassanini, J.-C. Cerottini, and I. F. Luescher Effects of Epitope Modification on T Cell Receptor-Ligand Binding and Antigen Recognition by Seven H-2Kd-restricted Cytotoxic T Lymphocyte Clones Specific for a Photoreactive Peptide Derivative J. Exp. Med., February 17, 1997; 185(4): 629 - 640. [Abstract] [Full Text] [PDF]

				J. Madrenas, L. A. Chau, J. Smith, J. A. Bluestone, and R. N. Germain The Efficiency of CD4 Recruitment to Ligand-engaged TCR Controls the Agonist/Partial Agonist Properties of Peptide-MHC Molecule Ligands J. Exp. Med., January 20, 1997; 185(2): 219 - 230. [Abstract] [Full Text] [PDF]

				M. R. Burk, I. Carena, A. Donda, F. Mariani, L. Mori, and G. De Libero Functional Inactivation in the Whole Population of Human Vgamma 9/Vdelta 2 T Lymphocytes Induced By a Nonpeptidic Antagonist J. Exp. Med., January 1, 1997; 185(1): 91 - 98. [Abstract] [Full Text] [PDF]